Method of treating herpes infections with 2',5'-oligoadenylate-2

Details Method of treating herpes infections with 2',5'-oligoadenylate-2 Method of treating herpes infections with 2',5'-oligoadenylate-2

1997-01-16

1999-09-21

Weber, Jon P.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 252, A01N 4304, C07H 2102

Patent

active

059554460

ABSTRACT:
The present invention provides methods for treating herpes infections in a subject in need of such treatment, by the administration of 2'-5' oligoadenylate-2',3'-cyclophosphate compounds. Pharmaceutical formulations comprising 2'-5' oligoadenylate-2',3'-cyclophosphate and compounds thereof are also provided.

REFERENCES:
patent: 4464359 (1984-08-01), Suhadolnik et al.
patent: 4476301 (1984-10-01), Imbach et al.
patent: 4515781 (1985-05-01), Torrence et al.
patent: 4539313 (1985-09-01), Suhadolnik et al.
patent: 4708935 (1987-11-01), Suhadolnik et al.
patent: 4859768 (1989-08-01), Suhadolnik et al.
patent: 4924624 (1990-05-01), Suhadolnik et al.
patent: 4981957 (1991-01-01), Lebleu et al.
patent: 4990498 (1991-02-01), Suhadolnik
patent: 5188897 (1993-02-01), Suhadolnik et al.
patent: 5405939 (1995-04-01), Suhadolnik et al.
patent: 5739013 (1998-04-01), Budowsky et al.
Liu et al. "Mechanism of Interferon Action III-Significace of pppA2'p5'A2'p5'A in the Antiviral Action of Interferon," Scientia Sinica (Series B) (1983) 26: 8: 809-815, 1983.
Goswami et al. "Mechanism of Inhibition of Herpesvirus Growth by 2',5'-Linked Trimer of 9-beta-D-Xylofuranosyladenine," Virology (1984) 137: 400-407, 1984.
Eppstein et al. "Xyloadenosine Analog of (A2'p)2-A Inhibits Replication of Herpes Simplex Viruses 1 and 2," Nature (1983) 302: 723-724, 1983.
Fujihara et al. "Effect of 2',5'-oligoadenylate on Herpes simplex virus-infected cells and preventive action of 2',5'-oligoadenylate on the lethal effects of HSV-2," J. Interferon Res. (1989) 9:691-707.
S. Shigeta et al., "Preparation of peptide conjugates with 2',5'-oligoadenylates as antitumor and antiviral agents," Chemical Abstracts 113:152984p (1990).
Doetsch et al.; "Core (2'-5')oligoadenylate and the cordycepin analog; Inhibitors of Epstein-Barr virus-induced transformation of human lymphocytes in the absence of interferon"; Proc. Natl. Acad. Sci. USA, 78(11):6699-6703 (1981).
Black et al.; "2',5'-Oligoadenylate Trimer Core and the Cordycepin Analog Augment the Tumorcidal Activity of Human Natural Killer Cells"; J. of Immunology, 135(5):2773-2777 (1984).
Henderson et al.; "Inhibition of Epstein-Barr Virus-Associated Nuclear Antigen (EBNA) Induction by (2',5')Oligoadenylate and the Cordycepin Analog: Mechanism of Action for Inhibition of EBV-Induced Transformation"; Virology, pp. 198-201 (1982), vol. 122.
Torrence et al.; "Methods for the Synthesis of Analogs of (2'-5')-Oligoadenylic Acid"; Methods in Enzymology, 119:522-529 (1986).
Devash et al.; "Measurement of Effect (2'-5')-Oligoadenylates and Analogs on Tobacco Mosaic Virus Replication"; Methods in Enzymology, 119:759-761 (1986).
Johnston et al.; "The Role of Interferon-induced proteins, double-stranded RNA and 2',5'-oligoadenylate in the interferon-mediated inhibition of viral translation"; Interferon, 3(7):201-298 (1984).
Suhadolnik et al.; "Measurement of Effect of (2'-5')-Oligoadenylates and Analogs on Protein Synthesis and Growth of Cells"; Methods in Enzymology, 119:667-675 (1986).
Nolan-Sorden et al.; "Photochemical Crosslinking in Oligonucleotide-Protein Complexes between a Bromine-Substituted 2-5A Analog and 2-5A-Dependent RNase by Ultraviolet Lamp or Laser"; Analytical Biochemistry, 184:298-304 (1990).
Itkes et al.; "A route to 2',5'-oligoadenylates with increased stability towards phosphodiesterases"; Febs Letters, 236(2):325-328 (1988).

Affiliated with

Also associated with

Rating

Method of treating herpes infections with 2',5'-oligoadenylate-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating herpes infections with 2',5'-oligoadenylate-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating herpes infections with 2',5'-oligoadenylate-2 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-80350